BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37715592)

  • 1. Combination of omalizumab with allergen immunotherapy versus immunotherapy alone for allergic diseases: A meta-analysis of randomized controlled trials.
    Zhang YY; Zhang M; Zhang JQ; Li QQ; Lu MP; Cheng L
    Int Forum Allergy Rhinol; 2024 Apr; 14(4):794-806. PubMed ID: 37715592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between allergen immunotherapy and omalizumab for treating asthma.
    Braido F; Corsico A; Rogkakou A; Ronzoni V; Baiardini I; Canonica GW
    Expert Rev Respir Med; 2015 Apr; 9(2):129-34. PubMed ID: 25578528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab and allergen immunotherapy for respiratory allergies: A mini-review from the Allergen-Immunotherapy Committee of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
    De Filippo M; Votto M; Caminiti L; Carella F; Castro G; Landi M; Olcese R; Panasiti I; Vernich M; Barberi S; Ciprandi G; Marseglia GL
    Allergol Immunopathol (Madr); 2022; 50(6):47-52. PubMed ID: 36335444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.
    Nurmatov U; Dhami S; Arasi S; Pajno GB; Fernandez-Rivas M; Muraro A; Roberts G; Akdis C; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; du Toit G; Ebisawa M; Eigenmann P; Knol E; Makela M; Nadeau KC; O'Mahony L; Papadopoulos N; Poulsen LK; Sackesen C; Sampson H; Santos AF; van Ree R; Timmermans F; Sheikh A
    Allergy; 2017 Aug; 72(8):1133-1147. PubMed ID: 28058751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihistamine premedication improves safety and efficacy of allergen immunotherapy.
    Wang L; Wang C; Lou H; Zhang L
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):363-371.e1. PubMed ID: 34052425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.
    Bozek A; Kozłowska R; Misiołek M; Ścierski W; Gawlik R
    Hum Vaccin Immunother; 2022 Nov; 18(6):2097818. PubMed ID: 35816437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
    Guilleminault L; Michelet M; Reber LL
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-IgE therapy in combination with allergen specific immunotherapy for seasonal allergic rhinitis.
    Stock P; Rolinck-Werninghaus C; Wahn U; Hamelmann E
    BioDrugs; 2007; 21(6):403-10. PubMed ID: 18020623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy of specific aeroallergens immunotherapy and omalizumab, in children with severe asthma.
    Valdesoiro-Navarrete L; León ME; Rodríguez M; Indiveri M; Ayats R; Larramona H; González MG; de la Cruz ÒA; García MB
    Allergol Immunopathol (Madr); 2022; 50(2):1-6. PubMed ID: 35257539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Immunologic Indicators During Allergen-Specific Immunotherapy for Allergic Rhinitis and Determinants of Variability: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Jiang Z; Xiao H; Liu S; Meng J
    Am J Rhinol Allergy; 2021 Nov; 35(6):910-922. PubMed ID: 33631946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis.
    Dhami S; Kakourou A; Asamoah F; Agache I; Lau S; Jutel M; Muraro A; Roberts G; Akdis CA; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci Ö; Mosges R; Palomares O; Pfaar O; Smolinska S; Sokolowska M; Asaria M; Netuveli G; Zaman H; Akhlaq A; Sheikh A
    Allergy; 2017 Dec; 72(12):1825-1848. PubMed ID: 28543086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
    Yang J; Lei S
    Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Clin Exp Allergy; 2018 Mar; 48(3):232-240. PubMed ID: 29315922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific allergen immunotherapy for the treatment of atopic eczema.
    Tam H; Calderon MA; Manikam L; Nankervis H; García Núñez I; Williams HC; Durham S; Boyle RJ
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD008774. PubMed ID: 26871981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen injection immunotherapy for seasonal allergic rhinitis.
    Calderon MA; Alves B; Jacobson M; Hurwitz B; Sheikh A; Durham S
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001936. PubMed ID: 17253469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials.
    Tsabouri S; Tseretopoulou X; Priftis K; Ntzani EE
    J Allergy Clin Immunol Pract; 2014; 2(3):332-40.e1. PubMed ID: 24811026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on omalizumab in allergen immunotherapy.
    Dantzer JA; Wood RA
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):559-568. PubMed ID: 34419967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control.
    Wagenmann M; Worm M; Akboga Y; Karjalainen M; Hohlfeld JM
    Allergy; 2019 Aug; 74(8):1480-1489. PubMed ID: 31025363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.